Miragen Therapeutics Inc.

13F holders, Q3 2025 (September 30)
2holders
0new positions
0sold out
$0.00avg. 13F price*

At the end of Q3 2025, 2 institutions reported holding Miragen Therapeutics Inc. in their 13F filings, unchanged from Q2 2025. 0 opened new positions and 0 sold out. The largest holders were Game Plan Financial Advisors, LLC ($0) and ORG Partners LLC ($0).

Company
Miragen Therapeutics Inc.
CUSIP
604CVR019
Latest filing quarter
Q3 2025

History

Number of 13F holders

012 Q1 2024: 2Q1 2024Q2 2024: 2Q2 2024Q3 2024: 2Q3 2024Q4 2024: 2Q4 2024Q1 2025: 2Q1 2025Q2 2025: 2Q2 2025Q3 2025: 2Q3 2025

Total Exit/New Position Q2 2025 → Q3 2025

InstitutionsTotal Value
New Positions0$0
Exits0$0

All 13F filers, Q2 2025 → Q3 2025: 3,000 shares sold, net −3,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 2 holders

Game Plan Financial Advisors, LLC 0.00% Reduce -42.9% 4,000 $0
ORG Partners LLC 0.00% No change 180 $0

"% of holder's portfolio" is MIRAGEN THERAPEUTICS INC's weight in each manager's 13F, not the share of Miragen Therapeutics Inc. the manager owns.